Thurston Springer Miller Herd & Titak Inc. Boosts Position in Axon Enterprise, Inc $AXON

Key Points

• Thurston Springer Miller Herd & Titak Inc. increased its stake in Axon Enterprise, Inc by 19.3% during Q2, bringing its total holdings to 3,873 shares valued at $3,206,000.
• Axon Enterprise recently reported earnings of $2.12 per share, exceeding estimates and reflecting a 32.6% year-over-year revenue increase for the quarter.
• Wall Street analysts have a consensus rating of "Moderate Buy" for Axon Enterprise, with an average price target of $837.69.

Thurston Springer Miller Herd & Titak Inc. lifted its position in shares of Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 19.3% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,873 shares of the biotechnology company's stock after purchasing an additional 627 shares during the quarter. Thurston Springer Miller Herd & Titak Inc.'s holdings in Axon Enterprise were worth $3,206,000 as of its most recent SEC filing.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. LaSalle St. Investment Advisors LLC lifted its holdings in Axon Enterprise by 2.1% in the 1st quarter. LaSalle St. Investment Advisors LLC now owns 777 shares of the biotechnology company's stock valued at $408,000 after purchasing an additional 16 shares in the last quarter. Smartleaf Asset Management LLC grew its position in Axon Enterprise by 5.0% in the 1st quarter. Smartleaf Asset Management LLC now owns 379 shares of the biotechnology company's stock valued at $203,000 after acquiring an additional 18 shares in the last quarter. Pinion Investment Advisors LLC grew its position in Axon Enterprise by 3.0% in the 1st quarter. Pinion Investment Advisors LLC now owns 649 shares of the biotechnology company's stock valued at $341,000 after acquiring an additional 19 shares in the last quarter. Kentucky Retirement Systems grew its position in shares of Axon Enterprise by 0.4% during the first quarter. Kentucky Retirement Systems now owns 4,953 shares of the biotechnology company's stock worth $2,605,000 after buying an additional 19 shares in the last quarter. Finally, WCM Investment Management LLC grew its position in shares of Axon Enterprise by 0.8% during the first quarter. WCM Investment Management LLC now owns 2,441 shares of the biotechnology company's stock worth $1,306,000 after buying an additional 19 shares in the last quarter. Institutional investors and hedge funds own 79.08% of the company's stock.

Axon Enterprise Price Performance

Shares of AXON opened at $756.13 on Friday. Axon Enterprise, Inc has a 52 week low of $375.71 and a 52 week high of $885.91. The firm has a market cap of $59.36 billion, a price-to-earnings ratio of 186.70, a PEG ratio of 27.57 and a beta of 1.40. The company has a current ratio of 2.95, a quick ratio of 2.71 and a debt-to-equity ratio of 0.63. The stock has a 50 day moving average of $761.10 and a 200-day moving average of $687.25.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last announced its earnings results on Monday, August 4th. The biotechnology company reported $2.12 earnings per share for the quarter, beating the consensus estimate of $1.54 by $0.58. Axon Enterprise had a return on equity of 6.80% and a net margin of 13.64%.The firm had revenue of $668.54 million for the quarter, compared to the consensus estimate of $641.77 million. During the same quarter in the previous year, the business earned $1.20 EPS. The firm's revenue for the quarter was up 32.6% on a year-over-year basis. Axon Enterprise has set its FY 2025 guidance at EPS. As a group, analysts forecast that Axon Enterprise, Inc will post 5.8 EPS for the current year.

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on the company. Wolfe Research initiated coverage on Axon Enterprise in a research note on Monday, July 7th. They set an "outperform" rating for the company. Northland Securities set a $800.00 price target on Axon Enterprise in a research note on Tuesday, August 5th. JMP Securities upped their price objective on Axon Enterprise from $725.00 to $825.00 and gave the stock a "market outperform" rating in a report on Tuesday, July 22nd. JPMorgan Chase & Co. raised their price target on Axon Enterprise from $730.00 to $850.00 and gave the company an "overweight" rating in a research report on Thursday, July 17th. Finally, Needham & Company LLC set a $870.00 price objective on shares of Axon Enterprise and gave the stock a "buy" rating in a research report on Tuesday, August 5th. Thirteen analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $837.69.

Insider Activity at Axon Enterprise

In other news, President Joshua Isner sold 15,919 shares of the stock in a transaction that occurred on Friday, August 15th. The stock was sold at an average price of $746.26, for a total value of $11,879,712.94. Following the completion of the transaction, the president directly owned 238,379 shares of the company's stock, valued at approximately $177,892,712.54. This represents a 6.26% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Jeffrey C. Kunins sold 7,891 shares of the stock in a transaction that occurred on Thursday, August 14th. The stock was sold at an average price of $750.10, for a total value of $5,919,039.10. Following the completion of the transaction, the insider directly owned 144,538 shares of the company's stock, valued at approximately $108,417,953.80. The trade was a 5.18% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 44,790 shares of company stock worth $34,304,947 in the last 90 days. Insiders own 4.40% of the company's stock.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc (NASDAQ:AXON - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.